Rare Skin Disorders in IBD Patients Treated with Anti-TNFs

    February 2014 in “ Journal of Crohn's and colitis ”
    Vanessa Prieto, Alexis Fernández, A. Velasco, Cecilia Pérez Piñero, Jazmina Umaña, Y. Jamanca, A Mora, Alvaro J. Ramos Rodriguez
    Image of study
    TLDR Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.
    In a study of 93 IBD patients treated with anti-TNFs, 6.45% developed severe psoriasiform reactions, necessitating the withdrawal of the treatment. Two patients (2.5%) developed alopecia universalis, with one having a history of alopecia areata, suggesting a potential risk factor. Ustekinumab was found to be an effective alternative for managing these adverse effects. Additionally, a case of molluscum contagiosum was resolved with podophyllin and cessation of immunosuppressive therapy.
    Discuss this study in the Community →